Skip to main content
main-content

2019 | Gelenkschmerzen und Muskelschmerzen | OriginalPaper | Buchkapitel

21. Gelenk- und Muskelschmerzen

verfasst von: Michael Bernateck, Christina Heppner, Peter Korsten, Heide Siggelkow

Erschienen in: Praktische Schmerzmedizin

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Arthrosen sind die häufigsten Gelenkerkrankungen weltweit und führen zu einer Verschlechterung der Gelenkfunktion sowie zu akuten, intermittierenden oder chronischen Gelenkschmerzen. Muskelschmerzen sind die häufigste Ursache für Beschwerden im Bewegungssystem.
Literatur
Zurück zum Zitat Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650 PubMedCrossRef Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650 PubMedCrossRef
Zurück zum Zitat Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, PignoloD RJ, Sellmeyer E (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31(1):16–35 PubMedCrossRef Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, PignoloD RJ, Sellmeyer E (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31(1):16–35 PubMedCrossRef
Zurück zum Zitat Adwan MH (2017) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Rheumatol Rep 19(1):3 PubMedCrossRef Adwan MH (2017) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Rheumatol Rep 19(1):3 PubMedCrossRef
Zurück zum Zitat Aletaha D et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588 Aletaha D et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588
Zurück zum Zitat Altman RD, Hochberg MC, Moskowitcz RW, Schnitzer TJ (2000) Recommendations for the medical management of Osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43:1905–1915 CrossRef Altman RD, Hochberg MC, Moskowitcz RW, Schnitzer TJ (2000) Recommendations for the medical management of Osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43:1905–1915 CrossRef
Zurück zum Zitat American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (20 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2004) Hygiene in Klinik und Praxis, 3. Aufl. mhp-Verlag, Wiesbaden, S 51 ff. www.​uni-duesseldorf.​de/​AWMF/​:​ AWMF-Leitlinien-Register Nr. 029/006. Zugegriffen im 03.2012 American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (20 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2004) Hygiene in Klinik und Praxis, 3. Aufl. mhp-Verlag, Wiesbaden, S 51 ff. www.​uni-duesseldorf.​de/​AWMF/​:​ AWMF-Leitlinien-Register Nr. 029/006. Zugegriffen im 03.2012
Zurück zum Zitat Anderson PA, FroyshteterW AB, Tontz L Jr (2013) Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res 28(2):372–382 PubMedCrossRef Anderson PA, FroyshteterW AB, Tontz L Jr (2013) Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res 28(2):372–382 PubMedCrossRef
Zurück zum Zitat Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, MpofuH S, Richards B (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 373(26):2534–2548 PubMedCrossRef Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, MpofuH S, Richards B (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 373(26):2534–2548 PubMedCrossRef
Zurück zum Zitat Baron R, Eberhart L, Kern K et al (2017) Tapentadol prolonged release for chronic pain: a review of clinical trials and 5 years of routine clinical practice data. Pain Pract 17(5):678–700 PubMedCrossRef Baron R, Eberhart L, Kern K et al (2017) Tapentadol prolonged release for chronic pain: a review of clinical trials and 5 years of routine clinical practice data. Pain Pract 17(5):678–700 PubMedCrossRef
Zurück zum Zitat Baumbach SF, Böcker W, Mutschler W, Schieker M (2012) Warum bricht die Wirbelsäule wo sie bricht? Osteologie 21:143–150 CrossRef Baumbach SF, Böcker W, Mutschler W, Schieker M (2012) Warum bricht die Wirbelsäule wo sie bricht? Osteologie 21:143–150 CrossRef
Zurück zum Zitat Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2005) Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2):CD005328 Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2005) Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2):CD005328
Zurück zum Zitat Berenbaum F (2008) New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 10:441–449 CrossRef Berenbaum F (2008) New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 10:441–449 CrossRef
Zurück zum Zitat Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, EriksenS EF, Cummings R (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822 PubMedCrossRef Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, EriksenS EF, Cummings R (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822 PubMedCrossRef
Zurück zum Zitat Braun J et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904 PubMedCrossRef Braun J et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904 PubMedCrossRef
Zurück zum Zitat Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 361(6):557–568 PubMedCrossRef Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 361(6):557–568 PubMedCrossRef
Zurück zum Zitat Burmester G, Lanas A, Biasucci L et al (2011) The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis 70:818–822 PubMedCrossRef Burmester G, Lanas A, Biasucci L et al (2011) The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis 70:818–822 PubMedCrossRef
Zurück zum Zitat Buttgereit F, Burmester G, Bijlsma JW (2005) Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA. Ann Rheum Dis 64:170–172 Buttgereit F, Burmester G, Bijlsma JW (2005) Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA. Ann Rheum Dis 64:170–172
Zurück zum Zitat Buttgereit F, Mehta D, Kirwan J et al (2013) Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis 72:204–210 PubMedCrossRef Buttgereit F, Mehta D, Kirwan J et al (2013) Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis 72:204–210 PubMedCrossRef
Zurück zum Zitat Cannon CP, Curtis SP, FitzGerald GA, Krum H, Bolognese JA, Bombardier C, Weinblatt ME, van der Heijde D, Laine L (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 18(9549):1771–1781 CrossRef Cannon CP, Curtis SP, FitzGerald GA, Krum H, Bolognese JA, Bombardier C, Weinblatt ME, van der Heijde D, Laine L (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 18(9549):1771–1781 CrossRef
Zurück zum Zitat Chan FK, Lanas A, Scheiman J et al (2010) Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomized trial. Lancet 376(9736):173–179 PubMedCrossRef Chan FK, Lanas A, Scheiman J et al (2010) Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomized trial. Lancet 376(9736):173–179 PubMedCrossRef
Zurück zum Zitat Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Parhami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Henderson WG et al (1996) Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2021–2027 PubMedCrossRef Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Parhami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Henderson WG et al (1996) Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2021–2027 PubMedCrossRef
Zurück zum Zitat Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, TuongC W, Ritchlin T (2016a) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheum 68(5):1060–1071 Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, TuongC W, Ritchlin T (2016a) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheum 68(5):1060–1071
Zurück zum Zitat Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381 PubMedPubMedCentralCrossRef Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381 PubMedPubMedCentralCrossRef
Zurück zum Zitat Creamer P (1999) Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 11:417–421 PubMedCrossRef Creamer P (1999) Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 11:417–421 PubMedCrossRef
Zurück zum Zitat Dachverband Osteologie (2011) DVO guideline 2009 for prevention, diagnosis and therapy of osteoporosis in adults. Osteologie 20:55–74 CrossRef Dachverband Osteologie (2011) DVO guideline 2009 for prevention, diagnosis and therapy of osteoporosis in adults. Osteologie 20:55–74 CrossRef
Zurück zum Zitat Dachverband Osteologie in Deutschland (DVO) (2017) Evidenz-basierte Empfehlungen zur Prävention und Therapie der Osteoporose. www.​dv-osteologie.​org. Zugegriffen im März 2012 Dachverband Osteologie in Deutschland (DVO) (2017) Evidenz-basierte Empfehlungen zur Prävention und Therapie der Osteoporose. www.​dv-osteologie.​org. Zugegriffen im März 2012
Zurück zum Zitat Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (1):CD002822 Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (1):CD002822
Zurück zum Zitat Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151–1154 PubMedCrossRef Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151–1154 PubMedCrossRef
Zurück zum Zitat Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G (1986) Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 39:313–317 PubMedCrossRef Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G (1986) Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 39:313–317 PubMedCrossRef
Zurück zum Zitat Dt. Ges. f. Orthopädie und Traumatologie u. Berufsverb. d. Ärzte f. Orthopädie (Hrsg) (2002) Intraartikuläre Punktionen und Injektionen. Leitlinien der Orthopädie, 2. Aufl. Dt. Ärzte-Verlag, Köln Dt. Ges. f. Orthopädie und Traumatologie u. Berufsverb. d. Ärzte f. Orthopädie (Hrsg) (2002) Intraartikuläre Punktionen und Injektionen. Leitlinien der Orthopädie, 2. Aufl. Dt. Ärzte-Verlag, Köln
Zurück zum Zitat Echtermeyer F, Bertrand J, Dreier R, Meinecke I et al (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown osteoarthritis. Nat Med 15:1072–1076 PubMedCrossRef Echtermeyer F, Bertrand J, Dreier R, Meinecke I et al (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown osteoarthritis. Nat Med 15:1072–1076 PubMedCrossRef
Zurück zum Zitat Favero M, Schiavon F, Riato L, Carraro V, Punzi L (2008) Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings. Autoimmun Rev 8(1):59–61 PubMedCrossRef Favero M, Schiavon F, Riato L, Carraro V, Punzi L (2008) Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings. Autoimmun Rev 8(1):59–61 PubMedCrossRef
Zurück zum Zitat Fiehn C, Holle J, Iking-Konert C et al (2018) S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten. Z Rheumatol 77(Suppl 2):35 PubMedCrossRef Fiehn C, Holle J, Iking-Konert C et al (2018) S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten. Z Rheumatol 77(Suppl 2):35 PubMedCrossRef
Zurück zum Zitat Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S (2010) Does land-based exercise reduce pain and disability associtated with hip osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthr Cartil 18:613–620 CrossRef Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S (2010) Does land-based exercise reduce pain and disability associtated with hip osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthr Cartil 18:613–620 CrossRef
Zurück zum Zitat Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, Watson KD, LuntD M, Symmons P (2011) Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 70(10):1810–1814 PubMedCrossRef Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, Watson KD, LuntD M, Symmons P (2011) Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 70(10):1810–1814 PubMedCrossRef
Zurück zum Zitat Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10(4):259–264 PubMedCrossRef Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10(4):259–264 PubMedCrossRef
Zurück zum Zitat Gossec L et al (2012) European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71:4–12 PubMedCrossRef Gossec L et al (2012) European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71:4–12 PubMedCrossRef
Zurück zum Zitat Gotzsche PC, Johansen HK (1998) Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. BMJ 316:811–818 PubMedPubMedCentralCrossRef Gotzsche PC, Johansen HK (1998) Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. BMJ 316:811–818 PubMedPubMedCentralCrossRef
Zurück zum Zitat Haibel H, Fendler C, Listing J, Callhoff J, Braun J, Sieper J (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73(1):243–246 PubMedCrossRef Haibel H, Fendler C, Listing J, Callhoff J, Braun J, Sieper J (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73(1):243–246 PubMedCrossRef
Zurück zum Zitat Haroon NN, Paterson JM, Li P, Inman RD, Haroon N (2015) Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163(6):409–416 PubMedCrossRef Haroon NN, Paterson JM, Li P, Inman RD, Haroon N (2015) Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163(6):409–416 PubMedCrossRef
Zurück zum Zitat Häuser W, Bock F, Engeser P, Hege-Scheuing G, Hüppe M, Lindena G, Maier C, Norda H, Radbruch L, Sabatowski R, Schäfer M, Schiltenwolf M, Schuler M, Sorgatz H, Tölle T, Willweber-Strumpf A, Petzke F (2015) Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz 29(1):109–130 PubMedCrossRef Häuser W, Bock F, Engeser P, Hege-Scheuing G, Hüppe M, Lindena G, Maier C, Norda H, Radbruch L, Sabatowski R, Schäfer M, Schiltenwolf M, Schuler M, Sorgatz H, Tölle T, Willweber-Strumpf A, Petzke F (2015) Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz 29(1):109–130 PubMedCrossRef
Zurück zum Zitat Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, American College of Rheumatology (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64(4):465–474 CrossRef Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, American College of Rheumatology (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64(4):465–474 CrossRef
Zurück zum Zitat Hochberg MC, Martel-Pelletier J, Monfort J et al (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75(1):37–44 PubMedCrossRef Hochberg MC, Martel-Pelletier J, Monfort J et al (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75(1):37–44 PubMedCrossRef
Zurück zum Zitat Hunter JA, Blyth TH (1999) A risk-benefit assessment of intra-articular corticosteroids in rheumatic disorders. Drug Saf 21:353–365 PubMedCrossRef Hunter JA, Blyth TH (1999) A risk-benefit assessment of intra-articular corticosteroids in rheumatic disorders. Drug Saf 21:353–365 PubMedCrossRef
Zurück zum Zitat Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, RalstonJ SH, Jarvik G (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361(6):569–579 PubMedPubMedCentralCrossRef Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, RalstonJ SH, Jarvik G (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361(6):569–579 PubMedPubMedCentralCrossRef
Zurück zum Zitat Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141 PubMedCrossRef Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141 PubMedCrossRef
Zurück zum Zitat Karreman MC, Luime JJ, Hazes JMW, Weel A (2017) The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 11(5):631–642 PubMed Karreman MC, Luime JJ, Hazes JMW, Weel A (2017) The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 11(5):631–642 PubMed
Zurück zum Zitat Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, YuenE CK, Lewiecki M (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221. e1–e10 CrossRef Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, YuenE CK, Lewiecki M (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221. e1–e10 CrossRef
Zurück zum Zitat Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Moricke R, Lopez-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230–240. https://​doi.​org/​10.​1016/​S0140-6736(17)32137-2 CrossRef Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Moricke R, Lopez-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230–240. https://​doi.​org/​10.​1016/​S0140-6736(17)32137-2 CrossRef
Zurück zum Zitat Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3–23 PubMedCrossRef Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3–23 PubMedCrossRef
Zurück zum Zitat Kiltz U, Baraliakos X, Regel A, Buhring B, Braun J (2017) Causes of pain in patients with axial spondyloarthritis. Clin Exp Rheumatol 35 Suppl 107(5):102–107 PubMed Kiltz U, Baraliakos X, Regel A, Buhring B, Braun J (2017) Causes of pain in patients with axial spondyloarthritis. Clin Exp Rheumatol 35 Suppl 107(5):102–107 PubMed
Zurück zum Zitat Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The arthritis and rheumatism council low-dose glucocorticoid study group. N Engl J Med 333:142–146 PubMedCrossRef Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The arthritis and rheumatism council low-dose glucocorticoid study group. N Engl J Med 333:142–146 PubMedCrossRef
Zurück zum Zitat Knopp JA, Diner BM, Blitz M, LyritisB GP, Rowe H (2005) Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16(10):1281–1290 PubMedCrossRef Knopp JA, Diner BM, Blitz M, LyritisB GP, Rowe H (2005) Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16(10):1281–1290 PubMedCrossRef
Zurück zum Zitat Köhm M, Behrens F (2017) Psoriasisarthritis : Aktuelle therapeutische Standards. Z Rheumatol 76(6):495–503 PubMedCrossRef Köhm M, Behrens F (2017) Psoriasisarthritis : Aktuelle therapeutische Standards. Z Rheumatol 76(6):495–503 PubMedCrossRef
Zurück zum Zitat Kroon FP, van der Burg LR, Ramiro S, Landewe RB, Buchbinder R, Falzon L, van der Heijde D (2015) Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev (7):CD010952 Kroon FP, van der Burg LR, Ramiro S, Landewe RB, Buchbinder R, Falzon L, van der Heijde D (2015) Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev (7):CD010952
Zurück zum Zitat Krüger K, Wollenhaupt J, Burmester GR et al (2012) S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der Rheumatoiden Arthritis. Z Rheumatol 71:592–603 PubMedCrossRef Krüger K, Wollenhaupt J, Burmester GR et al (2012) S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der Rheumatoiden Arthritis. Z Rheumatol 71:592–603 PubMedCrossRef
Zurück zum Zitat Kuo CF, See LC, Yu KH, Chou IJ, ChiouS MJ, Luo F (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52(1):127–134 CrossRef Kuo CF, See LC, Yu KH, Chou IJ, ChiouS MJ, Luo F (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52(1):127–134 CrossRef
Zurück zum Zitat Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662 PubMedCrossRef Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662 PubMedCrossRef
Zurück zum Zitat Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP (2007) Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Longterm (MEDAL) programme: a randomised comparison. Lancet 10(9560):465–473 CrossRef Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP (2007) Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Longterm (MEDAL) programme: a randomised comparison. Lancet 10(9560):465–473 CrossRef
Zurück zum Zitat Leder BZ, Tsai JN, Jiang LA, Lee H (2017) Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: the Denosumab and Teriparatide Follow-up study (DATA-Follow-up). Bone 98:54–58 PubMedCrossRef Leder BZ, Tsai JN, Jiang LA, Lee H (2017) Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: the Denosumab and Teriparatide Follow-up study (DATA-Follow-up). Bone 98:54–58 PubMedCrossRef
Zurück zum Zitat Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323 PubMedCrossRef Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323 PubMedCrossRef
Zurück zum Zitat Lippuner K, Johansson H, Kanis JA, Rizzoli R (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20(7):1131–1140 PubMedCrossRef Lippuner K, Johansson H, Kanis JA, Rizzoli R (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20(7):1131–1140 PubMedCrossRef
Zurück zum Zitat Löffler C, Sattler H, Peters L, Loffler U, Uppenkamp M, Bergner R (2015) Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides. J Rheumatol 42(3):513–520 PubMedCrossRef Löffler C, Sattler H, Peters L, Loffler U, Uppenkamp M, Bergner R (2015) Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides. J Rheumatol 42(3):513–520 PubMedCrossRef
Zurück zum Zitat Loock J, Haustedt N, Wollenhaupt J (2014) Septische Arthritis des Erwachsenen. Z Rheumatol 73(7):623–633; quiz 634–625 PubMedCrossRef Loock J, Haustedt N, Wollenhaupt J (2014) Septische Arthritis des Erwachsenen. Z Rheumatol 73(7):623–633; quiz 634–625 PubMedCrossRef
Zurück zum Zitat Margaretten ME, Kohlwes J, Moore D, Bent S (2007) Does this adult patient have septic arthritis? JAMA 297(13):1478–1488 PubMedCrossRef Margaretten ME, Kohlwes J, Moore D, Bent S (2007) Does this adult patient have septic arthritis? JAMA 297(13):1478–1488 PubMedCrossRef
Zurück zum Zitat Martinez-Ferrer A, Blasco J, Carrasco JL, Macho JM, Roman LS, Lopez A, Monegal A, Guanabens N, Peris P (2013) Risk factors for the development of vertebral fractures after percutaneous vertebroplasty. J Bone Miner Res 28(8):1821–1829 PubMedCrossRef Martinez-Ferrer A, Blasco J, Carrasco JL, Macho JM, Roman LS, Lopez A, Monegal A, Guanabens N, Peris P (2013) Risk factors for the development of vertebral fractures after percutaneous vertebroplasty. J Bone Miner Res 28(8):1821–1829 PubMedCrossRef
Zurück zum Zitat Mathews C, Coakley JG (2008) Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol 20(4):457–462 PubMedCrossRef Mathews C, Coakley JG (2008) Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol 20(4):457–462 PubMedCrossRef
Zurück zum Zitat Maugars Y, Mathis C, Berthelot JM, Charlier C, Prost A (1996) Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol 35(8):767–770 PubMedCrossRef Maugars Y, Mathis C, Berthelot JM, Charlier C, Prost A (1996) Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol 35(8):767–770 PubMedCrossRef
Zurück zum Zitat Modi A, Siris ES, Tang J, Sen S (2015) Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy. Curr Med Res Opin 31(4):757–765 PubMedCrossRef Modi A, Siris ES, Tang J, Sen S (2015) Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy. Curr Med Res Opin 31(4):757–765 PubMedCrossRef
Zurück zum Zitat Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333–338 PubMedPubMedCentralCrossRef Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333–338 PubMedPubMedCentralCrossRef
Zurück zum Zitat Morgan DS, Fisher D, MerianosB A, Currie J (1996) An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 117(3):423–428 PubMedPubMedCentralCrossRef Morgan DS, Fisher D, MerianosB A, Currie J (1996) An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 117(3):423–428 PubMedPubMedCentralCrossRef
Zurück zum Zitat Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, GlassJ EV, Krege H (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17(2):273–280 PubMedCrossRef Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, GlassJ EV, Krege H (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17(2):273–280 PubMedCrossRef
Zurück zum Zitat Odio CM, Ramirez T, Arias G, Abdelnour A, Hidalgo I, Herrera ML, Bolanos W, Alpizar J, Alvarez P (2003) Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 22(10):883–888 PubMedCrossRef Odio CM, Ramirez T, Arias G, Abdelnour A, Hidalgo I, Herrera ML, Bolanos W, Alpizar J, Alvarez P (2003) Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 22(10):883–888 PubMedCrossRef
Zurück zum Zitat Petrella RJ, Petrella M (2006) A prospective randomized, double-blind, placebo-controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 33:951–956 PubMed Petrella RJ, Petrella M (2006) A prospective randomized, double-blind, placebo-controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 33:951–956 PubMed
Zurück zum Zitat Pfeifer M, Gehlen M, Hinz C (2017) Spinal orthoses in the treatment of vertebral fractures with osteoporosis: a systematic review article. Z Rheumatol 76(10):860–868 PubMedCrossRef Pfeifer M, Gehlen M, Hinz C (2017) Spinal orthoses in the treatment of vertebral fractures with osteoporosis: a systematic review article. Z Rheumatol 76(10):860–868 PubMedCrossRef
Zurück zum Zitat Piper JM, Ray WA, Daughterty JR, Griffin MR (1991) Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 114:735–740 PubMedCrossRef Piper JM, Ray WA, Daughterty JR, Griffin MR (1991) Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 114:735–740 PubMedCrossRef
Zurück zum Zitat Poddubnyy D, Sieper J (2014) Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 26(4):377–383 PubMedCrossRef Poddubnyy D, Sieper J (2014) Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 26(4):377–383 PubMedCrossRef
Zurück zum Zitat Rau R, Wassenberg S, Zeidler H, LDPT-Study Group (2000) Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis – preliminary results of a multicenter, randomized, parallel, double blind study. Z Rheumatol 59(Suppl 2):II/90–II/96 CrossRef Rau R, Wassenberg S, Zeidler H, LDPT-Study Group (2000) Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis – preliminary results of a multicenter, randomized, parallel, double blind study. Z Rheumatol 59(Suppl 2):II/90–II/96 CrossRef
Zurück zum Zitat Rees F, Hui M, Doherty M (2014) Optimizing current treatment of gout. Nat Rev Rheumatol 10(5):271–283 PubMedCrossRef Rees F, Hui M, Doherty M (2014) Optimizing current treatment of gout. Nat Rev Rheumatol 10(5):271–283 PubMedCrossRef
Zurück zum Zitat Reveille JDM, Weisman H (2013) The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 345(6):431–436 PubMedPubMedCentralCrossRef Reveille JDM, Weisman H (2013) The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 345(6):431–436 PubMedPubMedCentralCrossRef
Zurück zum Zitat Ritchlin CT, ColbertD RA, Gladman D (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970 PubMedCrossRef Ritchlin CT, ColbertD RA, Gladman D (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970 PubMedCrossRef
Zurück zum Zitat Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sorensen IJ, Valle-Onate R, Weber U, Wei J, Sieper J (2011) The assessment of spondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31 PubMedCrossRef Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sorensen IJ, Valle-Onate R, Weber U, Wei J, Sieper J (2011) The assessment of spondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31 PubMedCrossRef
Zurück zum Zitat Sarawate CA, Patel PA, Schumacher HR, Yang W, BrewerA KK, Bakst W (2006) Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 12(2):61–65 PubMedCrossRef Sarawate CA, Patel PA, Schumacher HR, Yang W, BrewerA KK, Bakst W (2006) Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 12(2):61–65 PubMedCrossRef
Zurück zum Zitat Sattui SEK, Saag G (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10(10):592–602 PubMedCrossRef Sattui SEK, Saag G (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10(10):592–602 PubMedCrossRef
Zurück zum Zitat Schett G, Lories RJ, D’Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D (2017) Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 13(12):731–741 PubMedCrossRef Schett G, Lories RJ, D’Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D (2017) Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 13(12):731–741 PubMedCrossRef
Zurück zum Zitat Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34(1):195–202 PubMedCrossRef Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34(1):195–202 PubMedCrossRef
Zurück zum Zitat Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MC, WeinsteinM RS, Whyte P (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29(1):1–23 PubMedCrossRef Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MC, WeinsteinM RS, Whyte P (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29(1):1–23 PubMedCrossRef
Zurück zum Zitat Sharff KA, RichardsJ EP, Townes M (2013) Clinical management of septic arthritis. Curr Rheumatol Rep 15(6):332 PubMedCrossRef Sharff KA, RichardsJ EP, Townes M (2013) Clinical management of septic arthritis. Curr Rheumatol Rep 15(6):332 PubMedCrossRef
Zurück zum Zitat Sieper J, Poddubnyy D (2016) New evidence on the management of spondyloarthritis. Nat Rev Rheumatol 12(5):282–295 PubMedCrossRef Sieper J, Poddubnyy D (2016) New evidence on the management of spondyloarthritis. Nat Rev Rheumatol 12(5):282–295 PubMedCrossRef
Zurück zum Zitat Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M (2009) New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68(6):784–788 PubMedCrossRef Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M (2009) New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68(6):784–788 PubMedCrossRef
Zurück zum Zitat Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewe R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, VlamD K, Heijde V (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3–17 PubMedCrossRef Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewe R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, VlamD K, Heijde V (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3–17 PubMedCrossRef
Zurück zum Zitat Song IH, Poddubnyy DA, Rudwaleit M, Sieper J (2008) Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheum 58(4):929–938 PubMedCrossRef Song IH, Poddubnyy DA, Rudwaleit M, Sieper J (2008) Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheum 58(4):929–938 PubMedCrossRef
Zurück zum Zitat Stephan M, Karst M, Bernateck M (2015) Drug strategies in the treatment of chronic pain. Fortschr Neurol Psychiatr 83(7):402–413 PubMedCrossRef Stephan M, Karst M, Bernateck M (2015) Drug strategies in the treatment of chronic pain. Fortschr Neurol Psychiatr 83(7):402–413 PubMedCrossRef
Zurück zum Zitat Stolwijk C, Boonen A, van Tubergen A, Reveille JD (2012) Epidemiology of spondyloarthritis. Rheum Dis Clin N Am 38(3):441–476 CrossRef Stolwijk C, Boonen A, van Tubergen A, Reveille JD (2012) Epidemiology of spondyloarthritis. Rheum Dis Clin N Am 38(3):441–476 CrossRef
Zurück zum Zitat Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW 2nd, HamburgerM SA, Becker A (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306(7):711–720 PubMedCrossRef Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW 2nd, HamburgerM SA, Becker A (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306(7):711–720 PubMedCrossRef
Zurück zum Zitat Taurog JD, ChhabraR A, Colbert A (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574 PubMedCrossRef Taurog JD, ChhabraR A, Colbert A (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574 PubMedCrossRef
Zurück zum Zitat Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673 PubMedCrossRef Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673 PubMedCrossRef
Zurück zum Zitat Taylor TH, Mecchella JN, Larson RJ, KerinT KD, Mackenzie A (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 125(11):1126–1134 e1127 PubMedCrossRef Taylor TH, Mecchella JN, Larson RJ, KerinT KD, Mackenzie A (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 125(11):1126–1134 e1127 PubMedCrossRef
Zurück zum Zitat Terkeltaub RA, Furst DE, Bennett K, Kook KA, CrockettM RS, Davis W (2010) High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62(4):1060–1068 PubMedCrossRef Terkeltaub RA, Furst DE, Bennett K, Kook KA, CrockettM RS, Davis W (2010) High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62(4):1060–1068 PubMedCrossRef
Zurück zum Zitat Towheed TE, Judd MJ, Hochberg MC, Wells G (2004) Acetaminophen for osteoarthritis (Cochrane review). The Cochrane library, issue 1. Wiley, Chichester Towheed TE, Judd MJ, Hochberg MC, Wells G (2004) Acetaminophen for osteoarthritis (Cochrane review). The Cochrane library, issue 1. Wiley, Chichester
Zurück zum Zitat Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guanabens N, Obermayer-Pietsch B, Ralston SH, EastellM R, Zillikens C (2017) Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105:11–17 PubMedCrossRef Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guanabens N, Obermayer-Pietsch B, Ralston SH, EastellM R, Zillikens C (2017) Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105:11–17 PubMedCrossRef
Zurück zum Zitat Tubergen, A van (2015). The changing clinical picture and epidemiology of spondyloarthritis. Nat Rev Rheumatol 11(2): 110-118. Tubergen, A van (2015). The changing clinical picture and epidemiology of spondyloarthritis. Nat Rev Rheumatol 11(2): 110-118.
Zurück zum Zitat Varkas G, Van den Bosch F (2016) NSAIDs in axial spondyloarthritis: to be continued …? Ann Rheum Dis 75(8):1423–1425 PubMedCrossRef Varkas G, Van den Bosch F (2016) NSAIDs in axial spondyloarthritis: to be continued …? Ann Rheum Dis 75(8):1423–1425 PubMedCrossRef
Zurück zum Zitat Venmans A, Klazen CA, Lohle PN, van Rooij WJ, Verhaar HJ, de Vries J, Mali WP (2010) Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol 31(8):1451–1453 PubMedCrossRefPubMedCentral Venmans A, Klazen CA, Lohle PN, van Rooij WJ, Verhaar HJ, de Vries J, Mali WP (2010) Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol 31(8):1451–1453 PubMedCrossRefPubMedCentral
Zurück zum Zitat Wang R, DasguptaM A, Ward M (2016) Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials. Ann Rheum Dis 75(6):1152–1160 PubMedCrossRef Wang R, DasguptaM A, Ward M (2016) Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials. Ann Rheum Dis 75(6):1152–1160 PubMedCrossRef
Zurück zum Zitat Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 68(2):282–298 CrossRef Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 68(2):282–298 CrossRef
Zurück zum Zitat Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52:3371–3380 PubMedCrossRef Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52:3371–3380 PubMedCrossRef
Zurück zum Zitat Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M (1999) Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 58(4):214–219 PubMedPubMedCentralCrossRef Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M (1999) Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 58(4):214–219 PubMedPubMedCentralCrossRef
Zurück zum Zitat WHO (1994) Assessment of fracture risk and and its application to screening for postmenopausal osteoporosis. WHO, Geneva WHO (1994) Assessment of fracture risk and and its application to screening for postmenopausal osteoporosis. WHO, Geneva
Zurück zum Zitat Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F (2003) Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. J Rheumatol 42:1254–1259 CrossRef Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F (2003) Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. J Rheumatol 42:1254–1259 CrossRef
Metadaten
Titel
Gelenk- und Muskelschmerzen
verfasst von
Michael Bernateck
Christina Heppner
Peter Korsten
Heide Siggelkow
Copyright-Jahr
2019
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-662-57487-4_22

Passend zum Thema

ANZEIGE

Erfolgreiche Opioidrotation von Hydromorphon zu Oxycodon OD

Der Fall zeigt, wie ein komplexes chronisches Schmerzsyndrom nach multiplen operativen Eingriffen (u.a. TEP), begleitet von starker Depression und Schlafstörungen, durch eine Therapieoptimierung zu einer deutlichen Verbesserung der Schmerzsymptomatik und der Lebensqualität führen kann.

ANZEIGE

Kasuistik - Chronische Schmerzstörung nach Gürtelrose im Gesicht

Eine Schmerztherapie bei Herpes Zoster sollte wegen des Chronifizierungsrisikos nicht zu zögerlich angesetzt werden. Dieser Fall zeigt, wie starke neuropathische Schmerzen wirksam und Compliance-fördernd mit Oxycodon-Präparaten behandelt werden können, die über 24 Stunden retardiert sind.

ANZEIGE

Schmerztherapie erleichtern - Auf 1x im Leben

Wie Sie bei starken chronischen Schmerzen die Therapie Ihrer Patienten mit Hilfe von ultraretardierten oralen Opioiden praxisrelevant optimieren und die Compliance sowie Lebensqualität Ihrer Patienten effektiv verbessern können, das erfahren Sie anschaulich in den folgenden Beiträgen.